NHC — National Healthcare Share Price
0.000.00%
Last trade - 00:00- $1.46bn
- $1.39bn
- $1.31bn
- 93
- 66
- 34
- 70
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.49 | ||
| Price to Tang. Book | 1.85 | ||
| Price to Free Cashflow | 18.35 | ||
| Price to Sales | 1.12 | ||
| EV to EBITDA | 10.43 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 6.73% | ||
| Return on Equity | 10.79% | ||
| Operating Margin | 6.64% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 1,028.22 | 1,074.3 | 1,085.74 | 1,141.54 | 1,307.38 | n/a | n/a | 5.58% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +17.29 | +106.96 | -93.21 | +493.55 | +42.47 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
National HealthCare Corporation is a senior healthcare company. The Company's principal business is the operation of skilled nursing facilities, assisted living facilities, independent living facilities, homecare and hospice agencies, and behavioral health hospitals. Its business activities include providing sub-acute and post-acute skilled nursing care, intermediate nursing care, rehabilitative care, memory and Alzheimer's care, senior living services, home health care services, hospice services, and behavioral health services. In addition, it provides management services, accounting and financial services, as well as insurance services to third-party operators of healthcare facilities. The Company operates or manages over 80 skilled nursing facilities with 10,341 licensed beds, 26 assisted living facilities with 1,413 units, nine independent living facilities, three behavioral health hospitals, 34 homecare agencies, and 33 hospice agencies located in nine states.
Directors
- Robert Adams NEC (74)
- R. Michael Ussery PRE (62)
- Stephen Flatt CEO (65)
- Brian Kidd SVP (46)
- B. Anderson Flatt SVP (59)
- Josh McCreary SVP (48)
- Jeffrey Smith SVP (57)
- Vicki Dodson SVP (59)
- Leroy McIntosh SVP (60)
- W. Andrew Adams DRC (75)
- J. Paul Abernathy IND (85)
- Ernest Burgess IND (81)
- Emil Hassan IND (74)
- Richard LaRoche IND (75)
- Sandra Trail IND
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- September 26th, 1997
- Public Since
- July 13th, 1983
- No. of Shareholders
- 19,080
- No. of Employees
- 14,962
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- NYSE MKT
- Shares in Issue
- 15,461,829
- Address
- 100 E. Vine St, MURFREESBORO, 37130
- Web
- https://nhccare.com/
- Phone
- +1 6158902020
- Auditors
- Ernst & Young LLP
Upcoming Events for NHC
Q1 2025 National Healthcare Corp Earnings Release
National Healthcare Corp Annual Shareholders Meeting
Q2 2025 National Healthcare Corp Earnings Release
Similar to NHC
Cryo-Cell International
NYSE MKT
FAQ
What is the National Healthcare share price?
As of Today at 22:12 UTC, shares in National Healthcare are trading at $94.58. This share price information is delayed by 15 minutes.
How has the National Healthcare share price performed this year?
Shares in National Healthcare last closed at $94.58 and the price had moved by +4.2% over the past 365 days. In terms of relative price strength the National Healthcare share price has underperformed the S&P500 Index by -3.82% over the past year.
What are the analyst and broker recommendations for National Healthcare?
There is no consensus recommendation for this security.
Find out moreWhat is the National Healthcare dividend yield?
The National Healthcare dividend yield is 2.54% based on the trailing twelve month period.
Does National Healthcare pay a dividend?
Last year, National Healthcare paid a total dividend of $2.40, and it currently has a trailing dividend yield of 2.54%. We do not have any data on when National Healthcare is to next pay dividends.
When does National Healthcare next pay dividends?
We do not have data on when National Healthcare is to next pay dividends. The historic dividend yield on National Healthcare shares is currently 2.54%.
How do I buy National Healthcare shares?
To buy shares in National Healthcare you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of National Healthcare?
As of the previous close price of $94.58, shares in National Healthcare had a market capitalisation of $1.46bn.
Where are National Healthcare shares listed?
Here are the trading details for National Healthcare:
- Country of listing: United States
- Exchange: ASQ
- Ticker Symbol: NHC
What kind of share is National Healthcare?
Based on an overall assessment of its quality, value and momentum National Healthcare is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a National Healthcare share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the National Healthcare share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like National Healthcare. Over the past six months, its share price has underperformed the S&P500 Index by -16.01%.
As of the last closing price of $94.58, shares in National Healthcare were trading -16.44% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the National Healthcare PE Ratio?
The National Healthcare PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $94.58.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of National Healthcare?
National Healthcare's management team is headed by:
- Robert Adams - NEC
- R. Michael Ussery - PRE
- Stephen Flatt - CEO
- Brian Kidd - SVP
- B. Anderson Flatt - SVP
- Josh McCreary - SVP
- Jeffrey Smith - SVP
- Vicki Dodson - SVP
- Leroy McIntosh - SVP
- W. Andrew Adams - DRC
- J. Paul Abernathy - IND
- Ernest Burgess - IND
- Emil Hassan - IND
- Richard LaRoche - IND
- Sandra Trail - IND